Being told your scans are normal while you're in agony is its own kind of diagnosis.
For roughly one in ten women in the United Kingdom, a condition that reshapes tissue within the body has long resisted the gaze of modern medicine, leaving patients in pain and in doubt for an average of nine years before receiving a name for their suffering. Researchers at Oxford University have now developed a CT scanning technique using a molecular tracer that seeks out the biological signatures of early endometriosis — catching what conventional imaging routinely misses. The advance is still in its earliest stages, but it carries the weight of something larger: the possibility that medicine might finally learn to see what it has so long overlooked.
- Women with endometriosis have endured a diagnostic wilderness of nearly a decade on average, their pain repeatedly attributed to stress, IBS, or the ordinary burden of womanhood.
- Standard imaging — ultrasound and MRI — consistently fails to detect early-stage disease, leaving surgery as the only reliable confirmation and creating years of compounding physical and emotional damage.
- Oxford researchers have piloted a CT scan paired with the molecular tracer maraciclatide, which latches onto newly forming blood vessels characteristic of endometriosis, correctly identifying the condition in 16 of 19 patients and catching cases invisible to conventional scans.
- The technique is promising but not yet proven — radiation exposure must be weighed carefully, and larger clinical trials are required before this method could enter standard medical practice.
- For patients like charity co-founder Gabriella Pearson, who went undiagnosed for over a decade while the disease damaged her bowel, bladder, and ovary, the stakes of getting this right extend far beyond medicine into careers, fertility, and years of life already lost.
For years, thousands of women in Britain have moved through a diagnostic maze that ends, again and again, at the same wall: a scan that shows nothing, a doctor who sends them home. Endometriosis — tissue resembling the womb's lining growing where it shouldn't — affects one in ten women in the UK, yet the average journey from first symptoms to confirmed diagnosis spans nine years. Researchers at Oxford University now believe they may have found a way to shorten that journey dramatically.
The core problem is that conventional imaging is largely blind to the disease in its early stages. Ultrasounds and MRIs miss it routinely, and the only certain diagnostic method remains laparoscopy — a surgical procedure that can itself take years to access. Women arrive at appointments with debilitating pain only to be told their results are normal, their suffering attributed to stress or irritable bowel syndrome.
The new approach pairs a CT scan with a molecular tracer called maraciclatide, designed to bind to areas of new blood vessel growth — a biological marker of early endometriosis. In a pilot study of 19 patients, the technique correctly identified the presence or absence of the condition in 16 cases, detecting disease that standard imaging had failed to find. Lead researcher Dr. Tatjana Gibbons describes it as a highly promising tool, particularly for the most common and hardest-to-spot form of the condition.
The human cost of diagnostic delay is embodied in the experience of Gabriella Pearson, co-founder of the Menstrual Health Project. Her symptoms began at ten; she wasn't diagnosed until 23. In the intervening years, endometriosis damaged her bowel, bladder, and ovary, disrupted her education and career, and left lasting marks on her mental health and fertility. The same ultrasound scan was interpreted differently by different doctors — the same image, two contradictory stories.
Experts not involved in the study have welcomed the preliminary findings while urging caution. Radiation exposure requires careful consideration, and a pilot study is only a beginning — larger trials must follow before the technique can become routine. But the possibility of a scan that genuinely sees the disease early represents something beyond a clinical milestone. It is, for many women, the possibility of being believed before the damage is already done.
For years, thousands of women in Britain have endured a diagnostic odyssey that leaves them in pain, doubting themselves, and often told their scans look normal. Endometriosis—a condition where tissue similar to the womb's lining grows elsewhere in the body—affects one in ten women in the UK, yet the average time from first symptoms to diagnosis stretches across nine years. Now researchers at Oxford University believe they may have found a way to collapse that timeline from years into months.
The problem is straightforward: conventional imaging misses the disease. Ultrasounds and MRI scans, the standard tools doctors reach for, often fail to detect early-stage endometriosis. Women arrive at appointments with debilitating pain—heavy periods that stop them from functioning, exhaustion that won't lift, abdominal agony—only to be told their scans are normal. They're sent home. They're told it's stress, or irritable bowel syndrome, or simply the price of being a woman. The only way to confirm endometriosis with certainty is through laparoscopy, a surgical procedure where a camera is threaded through a small cut in the abdomen. Getting that surgery can itself take years.
The new technique combines a CT scan with a molecular tracer called maraciclatide, which attaches to areas where new blood vessels are forming—a hallmark of early endometriosis growth. In a pilot study of 19 patients, the method correctly identified whether endometriosis was present or absent in 16 women. It caught 14 of 17 cases that were later confirmed by surgery, picking up disease that standard imaging had missed. Dr. Tatjana Gibbons, who led the research, describes the findings as offering "a highly promising diagnostic and monitoring tool, particularly for superficial peritoneal endometriosis," the most common form and also the hardest to spot.
The human weight of diagnostic delay becomes clear in the story of Gabriella Pearson, co-founder of the Menstrual Health Project charity. She was ten when her periods became debilitating. For six years she cycled through doctors, each offering a different explanation: it's normal, it's IBS, it's stress. She wasn't diagnosed until age 23, after more than a decade of worsening symptoms and misdiagnoses. By then, endometriosis had damaged her bowel, bladder, and ovary. The pain and complications derailed her education and career. The ripple effects spread into her mental health, finances, and fertility. "If I had been listened to and diagnosed earlier I would have been in a very different position now," she says. She eventually underwent surgery to get a definitive answer, partly because different doctors interpreted her ultrasound differently—the same scan read as two different stories depending on who was looking.
Dr. Lucy Whitaker, a gynaecologist at the University of Edinburgh who was not involved in the study, calls the preliminary data "really exciting" and points to a "desperate need for new non-invasive imaging techniques." If the findings hold up in larger trials, she says, it could allow doctors to intervene earlier and help people access diagnosis and treatment at a younger age. There are caveats: the scans involve radiation exposure, which needs careful weighing against the risks of surgical diagnosis. And this is still a pilot study. Larger clinical trials will be needed to confirm the technique works as hoped.
But for women who have spent years in pain, dismissed or misdiagnosed, the possibility of a scan that actually sees what's happening in their bodies represents something more than a technical advance. It represents being believed. It represents the chance to understand what's wrong before the damage spreads, before careers derail, before the condition steals years of life that could have been lived differently.
Citações Notáveis
If I had been listened to and diagnosed earlier I would have been in a very different position now.— Gabriella Pearson, co-founder of the Menstrual Health Project
This offers a highly promising diagnostic and monitoring tool, particularly for superficial peritoneal endometriosis, which is the most common and yet the hardest type to identify.— Dr. Tatjana Gibbons, lead researcher
A Conversa do Hearth Outra perspectiva sobre a história
Why does endometriosis take so long to diagnose in the first place? Is it just that doctors aren't looking hard enough?
It's more subtle than that. The disease hides. Early endometriosis doesn't show up on the scans doctors have been using for decades. A woman can have severe pain and a completely normal ultrasound, and both the scan and the pain are real. The doctor isn't being careless—the tool just isn't sensitive enough.
So this new scan with the tracer—it's basically making the disease visible where it was invisible before?
Exactly. The tracer lights up where new blood vessels are forming, which is where endometriosis is actively growing. It's like switching from a regular camera to thermal imaging. The disease was always there. Now you can actually see it.
In Gabriella's case, she had surgery eventually to get a diagnosis. Why couldn't the scans have done that job earlier?
Because surgery—laparoscopy—is the only way to definitively confirm endometriosis right now. Scans can suggest it, but they can't prove it. So women either live with uncertainty and pain, or they wait months or years for surgery. This new technique might let a scan do what surgery currently does, without the cut, without the recovery time.
What happens if this works in larger trials? Does it become standard care immediately?
Not immediately. There's the radiation exposure to consider—you're giving women CT scans, which involve radiation. Doctors will need to weigh that against the benefit of earlier diagnosis. But if the data holds, yes, this could become how endometriosis is diagnosed within a few years.
And for someone like Gabriella, who's already been damaged by years of delay—does this help her?
Not directly. But it might help the next generation of women avoid what she went through. That's the real point of this work.